The banker, the brothers, the friends and their frauds [Investment Executive - News]
Olema Pharmaceuticals, Inc. (OLMA)
Company Research
Source: Investment Executive - News
U.S. authorities charged three brothers, an investment banker and a couple of other friends for allegedly engaging in insider trading as well as a market manipulation scheme that involved impersonating doctors and breast cancer patients, and falsifying clinical trial results. The U.S. Securities and Exchange Commission (SEC) charged the brothers — Muhammad Saad Shoukat, Muhammad Arham Shoukat, and Muhammad Shahwaiz Shoukat — along with their friends Izunna Okonkwo, Daniyal Khan and Justin Kim, in connection with a couple of alleged market manipulation schemes and an alleged US$41-million insider trading scheme. In a parallel action, the U.S. Attorney's Office for the District of New Jersey also filed a variety of criminal charges (including securities fraud, insider trading, and a variety of conspiracy charges) against the six men. None of the allegations have been proven in court. In its complaint, the regulator alleged that between June 2020 and February 2024, Kim — a San F
Show less
Read more
Impact Snapshot
Event Time:
OLMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OLMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OLMA alerts
High impacting Olema Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
OLMA
News
- Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]Yahoo! Finance
- Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
- How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors [Yahoo! Finance]Yahoo! Finance
- Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.MarketBeat
- Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.MarketBeat
OLMA
Earnings
- 11/10/25 - Miss
OLMA
Sec Filings
- 1/12/26 - Form 8-K
- 1/12/26 - Form 144
- 12/30/25 - Form 4
- OLMA's page on the SEC website